Showing 21-30 of 38 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Combinatory Technologies to Optimized Localized Drug Delivery for Cell Therapies in T1D | The University of Alberta | Gregory Korbutt | Cures | 01-July-2024 to 30-June-2027 | $896,925.01 |
| Immune evasive islet-like cells by reduced immune recognition and local immune control | University Health Network | Maria Cristina Nostro | Cures | 01-June-2024 to 31-May-2027 | $999,509.50 |
| Modulation of immune cell fate and function by the islet secretome in health and diabetes | The University of British Columbia | Lauar de Brito Monteiro | Cures | 01-March-2024 to 28-February-2027 | $243,055.00 |
| Development of an antigen-specific lipid nanoparticle mRNA therapy for T1D | Integrated Nanotherapeutics, Inc | Chris Tam | Cures | 01-June-2024 to 30-November-2026 | $750,000.00 |
| Graft localized therapeutic delivery systems to enhance beta cell engraftment | The University of Alberta | Gregory Korbutt | Cures | 01-October-2023 to 30-September-2026 | $974,655.00 |
| Development of targeted nanoparticles for delivering therapeutics to islet cells for treatment of T1D | The Governing Council of the University of Toronto | Xiao Yu (Shirley) Wu | Cures | 01-April-2023 to 31-March-2027 | $899,710.00 |
| Phase 2 clinical study evaluating ZT-01 for the prevention of nocturnal hypoglycemia in Type 1 diabetes | Zucara Therapeutics Inc. | Richard Liggins | Improving Lives | 01-June-2023 to 30-June-2027 | $2,000,000.00 |
| Using a virtual care platform to deliver peer-led mental health support to rural and remote communities in BC: A randomized wait-list controlled trial of the REACHOUT intervention | The University of British Columbia | Tricia Tang | Improving Lives | 01-September-2022 to 31-December-2026 | $402,429.50 |
| Safe and Immune Cloaked Stem Cell-Derived Beta-Cells: Treatment for Type 1 Diabetes Mellitus | Sinai Health System | Andras Nagy | Cures | 01-October-2022 to 30-September-2026 | $1,474,390.51 |
| Regenerating Human Pancreatic β Cells to Treat Diabetes | Sunnybrook Research Institute | Robert Screaton | Cures | 01-May-2022 to 31-May-2026 | $900,000.00 |